Usher IF Collaborative

On June 3, 2022, Harvard Researcher, David Corey, Ph. D. (right), Laurie Kirkegaard, NPL Impact Agency (next to David Corey), Sarah Gauch Development Associate (third from left), Board Vice-Chair, Elliot Chaikof, MD, Ph. D. (left), Melissa Chaikof, Board Chair (head of table) and Frank Gentile, Ph. D. Board member and bio tech funder (second from left) formulated a three-year plan to achieve goals for the Collaborative including fundraising initiatives. Usher 1F Syndrome is a rare disease where children are born deaf and later learn that they will lose their vision.